To study the efficacy of air descemetopexy in the management of various types of descemet membrane detachment based on anterior segment – optical coherence tomography & to know the role of other gases Perfluoropropane (14% C3F8) and sulphur hexafluoride (20% SF6) in failed cases of air descemetopexy

---

Original Article

Author Details : Satya Prakash Singh, Mayank Srivastava, Basant Kumar Singh, Swarnima Agrahari, Santosh Kumar*

Volume : 5, Issue : 3, Year : 2019

Article Page : 124-129

https://doi.org/10.18231/j.ijooo.2019.032

Suggest article by email

Get Permission

---

Abstract

Purpose: To study the efficacy of air descemetopexy in the management of various types of descemet membrane detachment (DMD).
Materials and Methods: After ethical committee approval, clinical data of 40 patients during the period of December 2017 to December 2018, who developed DMD after cataract surgery were analysed.
Results: Majority of patients (n= 32, 80%) had severe generalized corneal edema, n = 4 had moderated corneal edema & n = 4 had localized mild corneal edema. Only air was sufficient to reattach DMD in majority of the patients (n=36, 90% cases), only 4 patients who had very large dmd failed to attach by air. In these patients repeat descemetopexy by 14% C3F8 gas was done which lead to attachment of descemet membrane with improvement of visual acuity in 3 cases. Complications due to increase intraocular pressure were noted with these gases.
Conclusion: Air descemetopexy is a safe & efficacious option for DMD repair in most of the cases and it is associated with less postop complications.

Keywords: Descemetopexy, Descemet membrane detachment (DMD).

How to cite : Singh S P, Srivastava M, Singh B K, Agrahari S, Kumar S, To study the efficacy of air descemetopexy in the management of various types of descemet membrane detachment based on anterior segment – optical coherence tomography & to know the role of other gases Perfluoropropane (14% C3F8) and sulphur hexafluoride (20% SF6) in failed cases of air descemetopexy. IP Int J Ocul Oncol Oculoplasty 2019;5(3):124-129

This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.